4.6 Review

Regulation of V-ATPase Assembly in Nutrient Sensing and Function of V-ATPases in Breast Cancer Metastasis

Journal

FRONTIERS IN PHYSIOLOGY
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphys.2018.00902

Keywords

V-ATPase; proton transport; acidification; regulated assembly; nutrient sensing; cancer; metastasis

Categories

Funding

  1. National Institutes of Health [GM34478]
  2. Breast Cancer Alliance Exceptional Project award

Ask authors/readers for more resources

V-ATPases are proton pumps that function to acidify intracellular compartments in all eukaryotic cells, and to transport protons across the plasma membrane of certain specialized cells. V-ATPases function in many normal and disease processes, including membrane traffic, protein degradation, pathogen entry, and cancer cell invasion. An important mechanism of regulating V-ATPase activity in vivo is regulated assembly, which is the reversible dissociation of the ATP-hydrolytic V-1 domain from the proton-conducting V-0 domain. Regulated assembly is highly conserved and occurs in response to various nutrient cues, suggesting that it plays an important role in cellular homeostasis. We have recently found that starvation of mammalian cells for either amino acids or glucose increases V-ATPase assembly on lysosomes, possibly to increase protein degradation (for amino acid homeostasis) or for the utilization of alternative energy sources (during glucose starvation). While regulation of assembly in response to amino acid starvation does not involve PI3K or mTORC1, glucose-regulated assembly involves both PI3K and AMPK. Another important form of V-ATPase regulation is the targeting of the enzyme to different cellular membranes, which is controlled by isoforms of subunit a. We have shown that V-ATPases are localized to the plasma membrane of highly invasive breast cancer cells, where they promote cell migration and invasion. Furthermore, overexpression of the a3 isoform is responsible for plasma membrane targeting of V-ATPases in breast tumor cells leading to their increased invasiveness.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Meeting Abstract Oncology

Clinical and preclinical evidence of an immune modulating role for the STAT3-targeting ASO AZD9150 and potential to enhance clinical responses to anti-PDL1 therapy

Patricia E. Mccoon, Rich Woessner, Shaun Grosskurth, Chris Womack, Mason Yamashita, Gene Hung, Robert MacLeod, Kirsten Bell, Mike Collins, Rachel DuPont, Vivian Jacobs, Michele Johnstone, Margaret Veldman-Jones, Paul Lyne

CANCER RESEARCH (2015)

Meeting Abstract Oncology

STAT3 inhibition enhances the activity of immune checkpoint inhibitors in murine syngeneic tumor models by creating a more immunogenic tumor microenvironment

Rich Woessner, Patricia McCoon, Kirsten Bell, Rachel DuPont, Mike Collins, Deborah Lawson, Prasad Nadella, Lourdes Pablo, Corinne Reimer, Vasu Sah, Paul Lyne

CANCER IMMUNOLOGY RESEARCH (2015)

Article Oncology

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies

Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao, Austin Dulak, Wenxian Wang, Philip Petteruti, Ian L. Dale, Scott Boiko, Tony Cheung, Jingwen Zhang, Shenghua Wen, Lillian Castriotta, Deborah Lawson, Michael Collins, Larry Bao, Miika J. Ahdesmaki, Graeme Walker, Greg O'Connor, Tammie C. Yeh, Alfred A. Rabow, Jonathan R. Dry, Corinne Reimer, Paul Lyne, Gordon B. Mills, Stephen E. Fawell, Michael J. Waring, Michael Zinda, Edwin Clark, Huawei Chen

MOLECULAR CANCER THERAPEUTICS (2016)

Article Oncology

Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations

Brendon Ladd, Anne Marie Mazzola, Teeru Bihani, Zhongwu Lai, James Bradford, Michael Collins, Evan Barry, Anne U. Goeppert, Hazel M. Weir, Kelly Hearne, Jonathan G. Renshaw, Morvarid Mohseni, Elaine Hurt, Sanjoo Jalla, Haifeng Bao, Robert Hollingsworth, Corinne Reimer, Michael Zinda, Stephen Fawell, Celina M. D'Cruz

ONCOTARGET (2016)

Article Oncology

Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model

Wei Yang, Muneeb Ahmed, Beenish Tasawwar, Tatyana Levchenko, Rupa R. Sawant, Michael Collins, Sabina Signoretti, Vladimir Torchilin, S. Nahum Goldberg

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2011)

Article Chemistry, Medicinal

Discovery of (+)-N-(3-Aminopropyl)-N-[1-(5-benzyl-3-metlyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-metlylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent

Maria-Elena Theoclitou, Brian Aquila, Michael H. Block, Patrick J. Brassil, Lillian Castriotta, Erin Code, Michael P. Collins, Audrey M. Davies, Tracy Deegan, Jayachandran Ezhuthachan, Sandra Filla, Ellen Freed, Haiqing Hu, Dennis Huszar, Muthusamy Jayaraman, Deborah Lawson, Paula M. Lewis, Murali V. P. Nadella, Vibha Oza, Maniyan Padmanilayam, Timothy Pontz, Lucienne Ronco, Daniel Russell, David Whitston, Xiaolan Zheng

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

GRK3 is essential for metastatic cells and promotes prostate tumor progression

Wenliang Lia, Nanping Ai, Suming Wang, Nandita Bhattacharya, Vladimir Vrbanac, Michael Collins, Sabina Signoretti, Yanhui Hu, Frederick M. Boyce, Karsten Gravdal, Ole J. Halvorsen, Hawa Nalwoga, Lars A. Akslen, Ed Harlow, Randolph S. Watnick

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Oncology

Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma

Scott A. Ezell, Michele Mayo, Teeru Bihani, Suprawee Tepsuporn, Suping Wang, Melissa Passino, Shaun E. Grosskurth, Mike Collins, Julie Parmentier, Corinne Reimer, Kate F. Byth

ONCOTARGET (2014)

Article Oncology

Comparisons of the Efficacy of a Jak1/2 Inhibitor (AZD1480) with a VEGF Signaling Inhibitor (Cediranib) and Sham Treatments in Mouse Tumors Using DCE-MRI, DW-MRI, and Histology

Mary E. Loveless, Deborah Lawson, Michael Collins, Murali V. Prasad Nadella, Corinne Reimer, Dennis Huszar, Jane Halliday, John C. Waterton, John C. Gore, Thomas E. Yankeelov

NEOPLASIA (2012)

Article Biochemistry & Molecular Biology

Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells

Christina M. McGuire, Michael P. Collins, GeHong Sun-Wada, Yoh Wade, Michael Forgac

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

AKT Ser/Thr kinase increases V-ATPase?dependent lysosomal acidification in response to amino acid starvation in mammalian cells

Michael P. Collins, Laura A. Stransky, Michael Forgac

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Oncology

STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1

Theresa A. Proia, Maneesh Singh, Richard Woessner, Larissa Carnevalli, Gayathri Bommakanti, Lukasz Magiera, Srimathi Srinivasan, Shaun Grosskurth, Mike Collins, Chris Womack, Matthew Griffin, Minwei Ye, Susan Cantin, Deanna Russell, Mingchao Xie, Adina Hughes, Nanhua Deng, Deanna A. Mele, Stephen Fawell, Simon Barry, Corinne Reimer, J. Carl Barrett, Patricia McCoon

CLINICAL CANCER RESEARCH (2020)

Article Biochemistry & Molecular Biology

Isoform a4 of the vacuolar ATPase a subunit promotes 4T1-12B breast cancer cell-dependent tumor growth and metastasis in vivo

Kevin Su, Michael P. Collins, Christina M. McGuire, Mohammed A. Alshagawi, Mariam K. Alamoudi, Zhen Li, Michael Forgac

Summary: The a4 isoform of the V-ATPase plays a significant role in the migration and invasion of breast cancer cells, as well as in the growth of tumors in vivo. Targeting this isoform may represent a novel therapeutic strategy to limit breast cancer growth and metastasis.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Pharmacology & Pharmacy

Inhibition of Platelet-Derived Growth Factor Receptor a by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancers

Naomi Laing, Brenda McDermott, Shenghua Wen, David Yang, Deborah Lawson, Mike Collins, Corinne Reimer, Peter A. Hall, Harriet Andersen, Michael Snaith, Xin Wang, Vahe Bedian, Zhu A. Cao, David Blakey

MOLECULAR PHARMACOLOGY (2013)

No Data Available